Webinar

Navigating Special Regulatory Pathways for Advanced Therapy Development Success

In this webinar, “Navigating Special Regulatory Pathways for Advanced Therapy Development Success,” our panel of regulatory experts discuss the special regulatory programs designed to accelerate drug development. They share their experiences and insights on navigating pathways such as the RMAT and PRIME designations and other initiatives from the FDA and EMA, which can significantly impact a company’s speed to market and overall success.

Explore how navigating special regulatory pathways can enhance drug development and help lead to improved patient access to innovative therapies.

Speakers:

Herbert Altmann - VP Market Access & Healthcare Consulting at Cencora
Christian Schneider - Vice President and Chief Medical Officer at Cencora Pharmalex
Monica King - Senior Manager, Regulatory Affairs at Cook Myosite
Nathalie Boeglin - Executive Director, Head of Regulatory Science, Early Stage Programs at Orchard Therapeutics
Arvind Natarajan - Senior Vice President, Process & Analytical Development at Iovance Biotherapeutics
Malou Gemeniano - Vice President, CMC Regulatory Affairs at Iovance Biotherapeutics